Table 2.
Cognitive performance following 1 week of AME or placebo supplementationa
| Cognitive tests | AME | Placebo | Intervention effectb | ||
|---|---|---|---|---|---|
| Baseline | After 1 week | Baseline | After 1 week | ||
| Attention and Psychomotor Speed | |||||
| RTI—reaction time (ms) | 378 ± 34 | 374 ± 37 | 378 ± 38 | 378 ± 39 | – 5 [– 15, 4]; p = 0.253 |
| RTI—movement time (ms) | 248 ± 43 | 239 ± 46 | 237 ± 42 | 242 ± 46 | – 12 [ – 21, – 2]; p = 0.019* |
| Memory | |||||
| DMS—total correct (%) | 93 ± 7 | 92 ± 8 | 90 ± 10 | 91 ± 9 | 0 [– 3, 3]; p = 0.879 |
| PAL – first-attempt memory score | 17 ± 3 | 18 ± 2 | 17 ± 1 | 18 ± 2 | 0 [– 1, 0]; p = 0.299 |
| PAL—total errors 12 trial | 7 ± 9 | 7 ± 9 | 6 ± 6 | 5 ± 7 | N/Ad |
| Executive Function | |||||
| MTT—incongruency cost (ms) | 57 ± 38 | 47 ± 37 | 58 ± 45 | 44 ± 39 | N/Ad |
| MTT—median latency (ms) | 533 ± 78 | 517 ± 74 | 542 ± 78 | 514 ± 65 | 12 [– 3, 28]; p = 0.113 |
| MTT—multitasking costc | 85 ± 78 | 59 ± 40 | 89 ± 74 | 69 ± 62 | – 8 [– 29, 14]; p = 0.478 |
| MTT—total errors | 2 ± 2 | 3 ± 3 | 3 ± 3 | 2 ± 2 | 1 [0, 2]; p = 0.151 |
| SWM—total errors 12 trial | 18 ± 14 | 17 ± 13 | 19 ± 14 | 16 ± 13 | 2 [– 3, 7]; p = 0.361 |
| SWM—strategy scorec | 8 ± 4 | 8 ± 5 | 8 ± 5 | 9 ± 5 | 0 [– 2, 1]; p = 0.556 |
DMS delayed matching to samples test, MTT multitasking test, PAL paired associates learning test, RTI reaction time test, SWM spatial working memory test
*Indicates p < 0.05
aData are presented as means ± SDs
bAnalysis was performed with a linear mixed model using intervention, period, and sex as fixed factors, and baseline values as covariate
cLow scores indicate better performance
dTreatment effects were not analyzed as a significant intervention*sex interaction was observed.